Patents Assigned to PRELUDE, INC.
  • CANCER BIOMARKERS AND METHODS OF USE THEREOF
    Publication number: 20120003639
    Abstract: Embodiments are provided for characterizing a biological sample. In some embodiments, one can estimate the risk that a subject with ductal carcinoma in situ will have a subsequent DCIS event and/or invasive cancers.
    Type: Application
    Filed: April 26, 2011
    Publication date: January 5, 2012
    Applicants: PRELUDE, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: KARLA KERLIKOWSKE, THEA D. TLSTY, MONA L. GAUTHIER, HAL K. BERMAN, TROY BREMER, ANNETTE M. MOLINARO